Efficacy of Interleukin-2 in Triple Negative Breast Cancer
Clinical trial NCT05821686 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05821686
- Sponsor
- Nova Scotia Health Authority
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-02
- Primary completion
- 2028-04-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.